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Abstract 
Background: HIV prevalence is increasing and more people are being infected despite the 
messages and the advertising.
1 Namibia has one of the highest HIV/AIDS prevalence rates in 
the world of 21.3% as at end of 2002. Two hundred and ten thousand people were estimated 
to be living with HIV/AIDS, more than one in five adults.
2
 Disclosure is very important for 
the prevention and control of HIV infection and is an essential part of behaviour 
modification, access and adherence to treatment. 
Aim: To determine knowledge, attitudes, and practices of HIV positive patients regarding 
disclosure of HIV results at Betesda clinic in Namibia. Objectives: To determine the 
participant profile, reasons for disclosure and non disclosure, to explore attitudes, knowledge 
and to understand practices of HIV positive patients with regard to disclosure of HIV results. 
 Methods: This was a cross-sectional descriptive study done at Betesda clinic a private 
clinic in Katutura a high density suburb of Windhoek. Two hundred and sixty three HIV 
positive patients tested after 2004 were entered into the study. Convenience sampling of all 
willing HIV positive patients was done. A questionnaire was used; a professional interpreter 
and a counsellor were available. Permission to conduct the study was obtained from Betesda 
management; ethical clearance was obtained from the Post Graduate Committee and Human 
Research Committee of the University of the Witwatersrand. Epi Info statistical software 
package version 3.4.1 July 3 2007 was used to analyze data. An expert statistician was 
utilized to assist with analyzing data. 
 Results: Two hundred and sixty three respondents were entered into the study. Sixty four 
percent were males, 41% were married, 28% were single, and 27% were cohabitating. 68% 
responded positively to what they thought about disclosure. Reasons for disclosure were 32% 
needed help, 25% partner to go for testing and 20% to let relatives know. Reasons for non 
disclosure were mainly fear of gossiping 79%. Seventy three percent had disclosed 60% 
within one week of knowing the results. Seventy three percent had disclosed to their partners, 
23% had disclosed to more than one person. People’s reactions were 43% supportive, 29% 
understood, 9% accepted and 6% angry. Upon disclosure 40% received help, 24% partners 
were tested, 23% received psychological support and 5% were stigmatized. Disclosure was 
found to be higher among the married and cohabitating. Conclusion: Knowledge of 
disclosure was positive; most thought disclosure was important and good. Attitudes and 
practices towards disclosure were encouraging; people were disclosing but to trusted 
individuals in the society and fear of stigma was still there but actual stigma was very low. 
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